Assessing coronary sinus blood flow in patients with coronary artery disease: A comparison of phase-contrast MR imaging with positron emission tomography
Jw. Koskenvuo et al., Assessing coronary sinus blood flow in patients with coronary artery disease: A comparison of phase-contrast MR imaging with positron emission tomography, AM J ROENTG, 177(5), 2001, pp. 1161-1166
Citations number
34
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Medical Research Diagnosis & Treatment
OBJECTIVE. This study was performed to determine whether MR imaging can be
used to reliably measure global myocardial blood flow and coronary flow res
erve in patients with coronary artery disease as compared with such measure
ments obtained by positron emission tomography (PET).
SUBJECTS AND METHODS. We measured myocardial blood flow first at baseline a
nd then after dipyridamole-induced hyperemia in 20 patients with coronary a
rtery disease. Myocardial blood flow as revealed by MR imaging was calculat
ed by dividing coronary sinus flow by the left ventricular mass. Coronary f
low reserve was calculated by dividing the rate of hyperemic flow by the ra
te of baseline flow.
RESULTS. Using MR imaging, myocardial blood flow at baseline was 0.73 +/- 0
.23 mL.min(-1).g(-1), and at hyperemia the blood flow was 1.43 +/- 0.37 mL.
min(-1). g(-1), yielding an average coronary flow reserve of 1.99 +/- 0.47.
Using PET, myocardial blood flow was 0.89 +/- 0.21 mL.min(-1).g(-1) at bas
eline and 1.56 +/- 0.42 mL.min(-1).g(-1) at hyperemia, yielding an average
coronary flow reserve of 1.77 +/- 0.36. The correlation of myocardial blood
flow and coronary flow reserve measurements for these two methods was an r
of 0.80 (p < 0.01) and an r of 0.50 (p < 0.05), respectively.
CONCLUSION. This study shows that myocardial blood flow measurements obtain
ed using MR imaging have a good correlation with corresponding PET measurem
ents. Coronary flow reserve measurements obtained using MR imaging had only
moderate correlation with PET-obtained measurements. Our results suggest t
hat MR imaging flow quantification could potentially be used for measuring
global myocardial blood flow in patients in whom interventional treatment f
or coronary artery disease is being evaluated.